Women with this condition can sometimes achieve a relatively low level of sexual excitement. Frustration, restlessness, and pelvic pain or a heavy pelvic sensation may occur because of vascular engorgement. On occasion, there may be no obvious reason why orgasm is unobtainable. In such cases, women report that they are unable to orgasm even if they have a caring, skilled partner, adequate time and privacy, and an absence of medical issues which would affect sexual satisfaction. About 15% of women report difficulties with orgasm, and 10% of women in the United States have never climaxed. 29% of women always have orgasms with their partner.Some social theorists believe that inability to orgasm may be related to residual psychosocial perceptions that female sexual desire is somehow wrong, and that this stems from the age of Victorian repression. It is thought that this view may impede some women – perhaps those raised in a more repressed environment – from being able to experience natural and healthy sexual feeling. Secondary anorgasmia
Secondary anorgasmia is the loss of the ability to have orgasms (as opposed to primary anorgasmia which indicates a person who has never had an orgasm) or loss of the ability to reach orgasm of past intensity. The cause may be alcoholism, depression, grief, pelvic surgery (such as total hysterectomy) or injuries, certain medications, death-grip, illness, estrogen deprivation associated with menopause, or rape. Prostatectomy
Secondary anorgasmia is close to 50% among males undergoing prostatectomy; 80% among radical prostatectomies.
Prostaglandin analogs such as latanoprost or bimatoprost, beta-blockers such as timolol, alpha-2 agonists such as brimonidine, muscarinic agents such as pilocarpine, hyperosmotic agents such as mannitol and carbonic anhydrase inhibitors such as acetazolamide, methazolamide or dorzolamide are the drugs used to decrease IOP. Surgical
If the elevated IOP is not responsive to medical treatment, glaucoma surgeries may be considered to prevent visual field loss. Epidemiology
It usually affects adults between the ages of twenty and fifty and is common in males than females. One study from Finland found that the incidence of disease is 0.4 and its prevalence is 1.9 out of 100,000. History
Posner and Schlossman first identified and described the syndrome in 1948. They  first reported a series of 9 cases and given the name glaucomatocyclitic crisis to describe this condition. == References ==